|
Volumn 6, Issue 3, 2001, Pages 186-189
|
Money or your life? The health-wealth trade-off in pharmaceutical regulation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG;
COST EFFECTIVENESS ANALYSIS;
DECISION MAKING;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
DRUG INDUSTRY;
ECONOMIC ASPECT;
ETHICS;
HEALTH CARE POLICY;
HEALTH ECONOMICS;
HUMAN;
MONEY;
PHARMACEUTICAL CARE;
PRIORITY JOURNAL;
PUBLIC HEALTH SERVICE;
REIMBURSEMENT;
REVIEW;
COMMUNITY HEALTH PLANNING;
DRUG INDUSTRY;
EFFICIENCY, ORGANIZATIONAL;
EUROPEAN UNION;
GREAT BRITAIN;
HEALTH CARE RATIONING;
HUMANS;
OUTCOME ASSESSMENT (HEALTH CARE);
PUBLIC HEALTH;
QUALITY OF HEALTH CARE;
STATE MEDICINE;
|
EID: 0034963269
PISSN: 13558196
EISSN: None
Source Type: Journal
DOI: 10.1258/1355819011927341 Document Type: Review |
Times cited : (6)
|
References (20)
|